KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Cash from Operations (2017 - 2025)

Historic Cash from Operations for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to -$35.4 million.

  • Guardant Health's Cash from Operations rose 3064.3% to -$35.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$222.9 million, marking a year-over-year increase of 1226.93%. This contributed to the annual value of -$239.9 million for FY2024, which is 2619.19% up from last year.
  • According to the latest figures from Q3 2025, Guardant Health's Cash from Operations is -$35.4 million, which was up 3064.3% from -$60.3 million recorded in Q2 2025.
  • Guardant Health's 5-year Cash from Operations high stood at -$16.3 million for Q1 2021, and its period low was -$111.9 million during Q2 2022.
  • Moreover, its 5-year median value for Cash from Operations was -$64.5 million (2024), whereas its average is -$65.4 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first tumbled by 55961.28% in 2021, then soared by 5931.81% in 2024.
  • Over the past 5 years, Guardant Health's Cash from Operations (Quarter) stood at -$77.0 million in 2021, then dropped by 17.87% to -$90.7 million in 2022, then grew by 13.25% to -$78.7 million in 2023, then increased by 18.06% to -$64.5 million in 2024, then surged by 45.11% to -$35.4 million in 2025.
  • Its Cash from Operations stands at -$35.4 million for Q3 2025, versus -$60.3 million for Q2 2025 and -$62.7 million for Q1 2025.